Första AP-fonden’s Indivior Pharmaceuticals INDV Stock Holding History

Första AP-fonden’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-29,908	Closed	–	–	563
2024 Q2	$0	Hold	29,908	–	–	﹤0.01%	577
2024 Q1	$0	Buy	+29,908	New	+$562K	﹤0.01%	574

Other funds holding INDV

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LIP

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

Första AP-fonden's INDV Position: Q3 2024 in Review

Första AP-fonden sold out of Indivior Pharmaceuticals (INDV) in Q3 2024, closing a stake of 29,908 shares.

Första AP-fonden first reported a position in INDV in Q1 2024 and held it in 2 quarters. The position peaked at $0 in Q2 2024. 103 funds tracked by Wall St. Rank hold INDV as of Q3 2024.

Första AP-fonden reported no remaining Indivior Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Första AP-fonden sold 29,908 Indivior Pharmaceuticals shares in Q3 2024.
Första AP-fonden first reported a position in Indivior Pharmaceuticals in Q1 2024 and held it in 2 quarters.
Första AP-fonden's Indivior Pharmaceuticals position peaked at $0 in Q2 2024.
103 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2024.

Based on Första AP-fonden's 13F filing for Q3 2024, filed 24 Oct 2024.